80 Participants Needed

Web Tool for Caregiver Burden in Alzheimer's Disease

SC
Overseen ByStudy Coordinator
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwell Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to learn if a newly-created website tool, called WeCareToFeedDysphagia, helps to reduce feelings of burden in care partners of patients with Alzheimer's disease and related dementias (AD/ADRD) who were diagnosed with trouble swallowing (oropharyngeal dysphagia). The main questions this first test (pilot) study aims to answer are:* With the data this pilot study will collect, how do we best measure how strong a relationship is between care partners who use WeCareToFeedDysphagia and reduced feelings of burden (effect size estimates)?* Is it possible (feasible) to successfully repeat this study in a larger clinical trial with more research participants?Researchers will compare a group of care partners who have access to the WeCareToFeedDysphagia tool (intervention) to a group of care partners who do not have access to the tool. Both groups will receive contact information for help from a speech language pathologist expert (enhanced usual care).Participants will:* be given access to the web tool and receive 3 text message reminders over 3 weeks to use the tool (intervention group only).* be asked to complete a remote, web-based survey three times: when enrolled in the study, at 1 month following patient leaving the hospital, and at 3 months following patient leaving the hospital.

Research Team

LS

Liron Sinvani, MD

Principal Investigator

Northwell Health

Eligibility Criteria

This trial is for primary care partners, aged 18 or older, of patients 65+ with Alzheimer's and related dementias who have swallowing difficulties. Participants must speak English, be the patient's legal representative or designated by them, and have web access.

Inclusion Criteria

I am proficient in English.
I am legally authorized to make decisions for a patient.
I have a device like a smartphone or computer that can access the internet.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants in the intervention group receive access to the WeCareToFeedDysphagia tool and receive 3 text message reminders over 3 weeks to use the tool.

3 weeks
Remote, web-based survey at baseline, 1 month, and 3 months

Follow-up

Participants are monitored for changes in care partner burden and quality of life at 1 month and 3 months post hospital discharge.

3 months
Remote, web-based survey at 1 month and 3 months

Treatment Details

Interventions

  • WeCareToFeedDysphagia
Trial Overview The study tests if a website tool called WeCareToFeedDysphagia can ease the burden on caregivers of dementia patients with swallowing issues. It compares caregivers using this tool to those without it while both receive expert contact info.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Control + WeCareToFeedDysphagiaExperimental Treatment1 Intervention
Participants receive usual care from their medical team and receive contact information for speech-language pathology follow-up care. Participants will also receive access to the WeCareToFeedDysphagia web tool and receive text message reminders to use the tool.
Group II: Enhanced ControlActive Control1 Intervention
Participants receive usual care from their medical team and receive contact information for speech-language pathology follow-up care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwell Health

Lead Sponsor

Trials
481
Recruited
470,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security